5,606
Views
21
CrossRef citations to date
0
Altmetric
Commentary

Mobilize to vaccinate: lessons learned from social mobilization for immunization in low and middle-income countries

ORCID Icon, , &
Pages 1208-1214 | Received 06 Aug 2019, Accepted 20 Aug 2019, Published online: 29 Oct 2019

References

  • WHO. The expanded programme on immunization. 2013. http://www.who.int/immunization/programmes_systems/supply_chain/benefits_of_immunization/en
  • WHO. Surveillance for vaccine preventable diseases. 2017. http://www.who.int/immunization/monitoring_surveillance/burden/VPDs/en
  • WHO. Global vaccine action plan 2011-2020. Geneva: WHO; 2013. http://www.who.int/immunization/global_vaccine_action_plan/en.
  • WHO. Diphtheria tetanus toxoid and pertussis (DTP3) by region. 2018. http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tswucoveragebcg.html
  • Dube E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger J. Vaccine hesitancy: an overview. Hum Vaccin Immunother. 2013;9:1763–73. doi:10.4161/hv.24657.
  • Dube E, Vivion M, MacDonald NE. Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications. Expert Rev Vaccines. 2015;14:99–117. doi:10.1586/14760584.2015.964212.
  • Eskola J, Duclos P, Schuster M, MacDonald NE. How to deal with vaccine hesitancy? Vaccine. 2015;33:4215–17. doi:10.1016/j.vaccine.2015.04.043.
  • Jarrett C, Wilson R, O’Leary M, Eckersberger E, Larson HJ. Strategies for addressing vaccine hesitancy - a systematic review. Vaccine. 2015;33:4180–90. doi:10.1016/j.vaccine.2015.04.040.
  • MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33:4161–64. doi:10.1016/j.vaccine.2015.04.036.
  • WHO. Ten threats to global health in 2019. Geneva: World Health Organization;2019.
  • Rogers T, Goldstein NJ, Fox CR. Social mobilization. Annu Rev Psychol. 2018;69:357–81. doi:10.1146/annurev-psych-122414-033718.
  • Ofosu-Amaah S. Social mobilization for immunization and primary health care. Asia-Pacific J Public Health. 1989;3:200–04. doi:10.1177/101053958900300305.
  • UNICEF. Social mobilization. New York: Unicef; 2015. https://www.unicef.org/cbsc/index_42347.html
  • UNICEF. Building trust in immunization: partnering with religious leaders and groups. New York, NY: UNICEF; 2004. p. 23–26.
  • UNICEF. Reaching the children: universal child immunization by 1990. New York, NY: UNICEF; 1987. p. 1–10.
  • Zarocostas J. UNICEF taps religious leaders in vaccination push. Lancet. 2004;363:1709. doi:10.1016/S0140-6736(04)16294-6.
  • Amin R, Hill RB, Horton SA, Kamara C, Chowdhury J. Immunization coverage, infant morbidity and infant mortality in Freetown, Sierra Leone. Soc Sci Med. 1982;1992:851–56.
  • WHO. WHO-UNICEF estimates of DTP3 coverage; 2018.
  • Organization WH. Ebola situation reports; 2016.
  • Elston JW, Cartwright C, Ndumbi P, Wright J. The health impact of the 2014-15 Ebola outbreak. Public Health. 2017;143:60–70. doi:10.1016/j.puhe.2016.10.020.
  • Blevins JB, Jalloh MF, Robinson DA. Faith and global health practice in Ebola and HIV emergencies. Am J Public Health. 2019;109:379–84. doi:10.2105/AJPH.2018.304870.
  • FOCUS1000. New Polio Vaccine in Sierra Leone: SUNI CSP engages communities to eradicate polio; 2017.
  • Deutsch N, Singh P, Singh V, Curtis R, Siddique AR. Legacy of polio-use of india’s social mobilization network for strengthening of the universal immunization program in India. J Infect Dis. 2017;216:S260–s6. doi:10.1093/infdis/jix068.
  • Siddique AR, Singh P, Trivedi G. Role of Social Mobilization (Network) in polio eradication in India. Indian Pediatr. 2016;53:S50–s6.
  • Weiss WM, Rahman MD, Solomon R, Ward D. Determinants of performance of supplemental immunization activities for polio eradication in Uttar Pradesh, India: social mobilization activities of the Social Mobilization Network (SM Net) and Core Group Polio Project (CGPP). BMC Infect Dis. 2013;13:17. doi:10.1186/1471-2334-13-17.
  • Coates EA, Waisbord S, Awale J, Solomon R, Dey R. Successful polio eradication in Uttar Pradesh, India: the pivotal contribution of the Social Mobilization Network, an NGO/UNICEF collaboration. Glob Health Sci Pract. 2013;1:68–83. doi:10.9745/GHSP-D-12-00018.
  • WHO. Bangladesh: Rohingya refugee crisis 2017-2018; 2018.
  • WHO. Diphtheria – Cox’s Bazar in Bangladesh; 2017.
  • Medecine Sans Frontiere. Bangladesh: emergence of diphtheria worsens situation of Rohingya refugees. Med Sans Front. 2017. http://www.msf.org/en/article/bangladesh-emergence-diphtheria-worsens-situation-rohingya-refugees
  • UNICEF. Bangladesh Humanitarian Situation Report No.22 (Rohingya Influx). UNICEF; 2018.
  • Jalloh MF, Bennett SD, Alam D, Kouta P, Lourenco D, Alamgir M, Feldstein LR, Ehlman DC, Abad N, Kapil N, et al. Rapid behavioral assessment of barriers and opportunities to improve vaccination coverage among displaced Rohingyas in Bangladesh, January 2018. Vaccine. 2019;37:833–38. doi:10.1016/j.vaccine.2018.12.042.
  • Tsu VD, Cernuschi T, LaMontagne DS. Lessons learned from HPV vaccine delivery in low-resource settings and opportunities for HIV prevention, treatment, and care among adolescents. J Acquir Immune Defic Syndr. 2014;66(Suppl 2):S209–S216. doi:10.1097/QAI.0000000000000175.
  • Kabakama S, KE G, Howard N, Mounier-Jack S, HE B, Griffiths UK, Feletto M, LaMontagne DS, Watson-Jones D. Social mobilisation, consent and acceptability: a review of human papillomavirus vaccination procedures in low and middle-income countries. BMC Public Health. 2016;16:834. doi:10.1186/s12889-016-3517-8.
  • Galagan SR, Paul P, Menezes L, LaMontagne DS. Influences on parental acceptance of HPV vaccination in demonstration projects in Uganda and Vietnam. Vaccine. 2013;31:3072–78. doi:10.1016/j.vaccine.2013.04.056.
  • Cover JK, Nghi NQ, LaMontagne DS, Huyen DT, Hien NT, Nga le T. Acceptance patterns and decision-making for human papillomavirus vaccination among parents in Vietnam: an in-depth qualitative study post-vaccination. BMC Public Health. 2012;12:629. doi:10.1186/1471-2458-12-629.
  • Watson-Jones D, Tomlin K, Remes P, Baisley K, Ponsiano R, Soteli S, de Sanjosé S, Changalucha J, Kapiga S, Hayes RJ, et al. Reasons for receiving or not receiving HPV vaccination in primary schoolgirls in Tanzania: a case control study. PLoS One. 2012;7:e45231. doi:10.1371/journal.pone.0045231.
  • Obregon R, Waisbord S. The complexity of social mobilization in health communication: top-down and bottom-up experiences in polio eradication. J Health Commun. 2010;15(Suppl 1):25–47. doi:10.1080/10810731003695367.
  • Shen AK, Fields R, McQuestion M. The future of routine immunization in the developing world: challenges and opportunities. Glob Health Sci Pract. 2014;2:381–94. doi:10.9745/GHSP-D-14-00137.
  • Nelson KN, Wallace AS, Sodha SV, Daniels D, Dietz V. Assessing strategies for increasing urban routine immunization coverage of childhood vaccines in low and middle-income countries: a systematic review of peer-reviewed literature. Vaccine. 2016;34:5495–503. doi:10.1016/j.vaccine.2016.09.038.
  • Habib MA, Soofi SB, Ali N, Hussain I, Tabassum F, Suhag Z, Anwar S, Ahmed I, Bhutta ZA. Knowledge and perceptions of polio and polio immunization in polio high-risk areas of Pakistan. J Public Health Policy. 2017;38:16–36. doi:10.1057/s41271-016-0056-6.
  • Pless Robert P, Bentsi‐Enchill Adwoa D, Duclos P. Monitoring vaccine safety during measles mass immunization campaigns: clinical and programmatic issues. J Infect Dis. 2003;187:SS291–S8. doi:10.1086/368049.
  • Cochi SL, Hegg L, Kaur A, Pandak C, Jafari H. The global polio eradication initiative: progress, lessons learned, and polio legacy transition planning. Health Aff (Millwood). 2016;35:277–83. doi:10.1377/hlthaff.2015.1104.
  • Smout EM, Enria L, Mooney T, Lees S, Watson-Jones D, Greenwood B, Leigh B, Larson HJ. Implementing a novel community engagement system during a clinical trial of a candidate Ebola vaccine within an outbreak setting. Int J Infect Dis. 2016;45:191. doi:10.1016/j.ijid.2016.02.444.
  • Habib MA, Soofi S, Cousens S, Anwar S, Haque NU, Ahmed I, Ali N, Tahir R, Bhutta ZA. Community engagement and integrated health and polio immunisation campaigns in conflict-affected areas of Pakistan: a cluster randomised controlled trial. Lancet Glob Health. 2017;5:e593–e603. doi:10.1016/S2214-109X(17)30184-5.
  • Thompson EL, Vamos CA, Piepenbrink R, Kadono M, Vázquez-Otero C, Matthes S, Daley EM. Human papillomavirus risk perceptions and relationship status: a barrier to HPV vaccination? Journal of Behavioral Medicine. 2019. doi:10.1007/s10865-019-00025-4.
  • Irwin KL, Jalloh MF, Corker J, Alpha Mahmoud B, Robinson SJ, Li W, James NE, Sellu M, Jalloh MB, Diallo AA, et al. Attitudes about vaccines to prevent Ebola virus disease in Guinea at the end of a large Ebola epidemic: results of a national household survey. Vaccine. 2017;35:6915–23. doi:10.1016/j.vaccine.2017.06.026.
  • Berlier M, Barry R, Shadid J, Sirica C, Brunier A, Hasan H, Bouma E. Communication challenges during the development and introduction of a new meningococcal vaccine in Africa. Clin Infect Dis. 2015;61:SS451–S8. doi:10.1093/cid/civ493.
  • Jalloh MF, Jalloh MB, Albert A, Wolff B, Callis A, Ramakrishnan A, Cramer E, Sengeh P, Pratt SA, Conteh L, et al. Perceptions and acceptability of an experimental Ebola vaccine among health care workers, frontline staff, and the general public during the 2014–2015 Ebola outbreak in Sierra Leone. Vaccine. 2019;37:1495–502. doi:10.1016/j.vaccine.2019.01.046.
  • Chatterjee S, Pant M, Haldar P, Aggarwal MK, Laxminarayan R. Current costs & projected financial needs of India’s Universal immunization programme. Indian J Med Res. 2016;143:801–08. doi:10.4103/0971-5916.192073.
  • MacQueen KM, Bhan A, Frohlich J, Holzer J, Sugarman J. Evaluating community engagement in global health research: the need for metrics. BMC Med Ethics. 2015;16:44. doi:10.1186/s12910-015-0033-9.